(Q37916327)

25 August 2017

1 reference

title

Neurocognitive impact of antiretroviral treatment: thinking long-term (English)

1 reference

25 August 2017

main subject

anti-retroviral agent

0 references

author name string

Megan E McPhail

series ordinal

1

1 reference

25 August 2017

Kevin R Robertson

series ordinal

2

1 reference

25 August 2017

publication date

1 December 2011

1 reference

25 August 2017

published in

Current HIV/AIDS reports

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

249-256

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0091-7

25 August 2017

exact match

0 references

cites work

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HIV-1 infection and cognitive impairment in the cART era: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Emerging issues in the neuropsychology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neurocognitive performance and quality of life in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HIV, the brain, children, HAART and 'neuro-HAART': a complex mix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Safety and efficacy of once-daily nevirapine dosing: a multicohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Response to combination antiretroviral therapy: variation by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Aging and HIV infection: a comparison between older HIV-infected persons and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HIV infection, inflammation, immunosenescence, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Successful cognitive aging in persons living with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The neuropsychology of HIV/AIDS in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neurocognition in individuals co-infected with HIV and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Influence of viral hepatitis on HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HCV Coinfection Associated with Slower Disease Progression in HIV-Infected Former Plasma Donors Naïve to ART

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

HIV-associated brain pathology in the United Kingdom: an epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Acceleration of HIV dementia with methamphetamine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Neuroimmunity, drugs of abuse, and neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The effect of previous alcohol abuse on cognitive function in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0091-7

Cognitive functioning in younger and older HIV-1-infected adults.

21 January 2018

1 reference

12 December 2020

Prevalence of cognitive disorders differs as a function of age in HIV virus infection

1 reference

12 December 2020

Use of drugs and alcohol by homosexually active men in relation to sexual practices

1 reference

12 December 2020

A new era of antiretroviral drug toxicity.

1 reference

12 December 2020

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center

1 reference

12 December 2020

10.1007/S11904-011-0091-7

Identifiers

DOI

1 reference

25 August 2017

1 reference